查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085738

心臟衰竭軟體市場：按類型、疾病類型、平台、應用、最終用戶和部署模式分類－2026-2032年全球市場預測

Heart Failure Software Market by Type, Disease Type, Platform, Application, End-User, Deployment Model - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心臟衰竭軟體市場將成長至 85.9 億美元，複合年成長率為 7.42%。

主要市場統計數據
基準年 2025 52億美元
預計年份：2026年 55.8億美元
預測年份 2032 85.9億美元
複合年成長率 (%) 7.42%

心臟衰竭軟體已從單純的臨床支援工具發展成為循環系統、人群健康管理和價值醫療的核心數位基礎設施層。此領域涵蓋遠端患者監護、臨床決策支援、心臟超音波圖和影像分析、護理協調、病人參與、藥物管理最佳化以及可在醫院、門診診所、居家醫療和保險公司之間使用的互通資料平台。

需求源自於心臟衰竭帶來的臨床負擔。心臟衰竭的盛行率老齡化成長而急劇上升，根據主要循環系統學會估計，已開發市場中約有1%至2%的成年人和超過10%的70歲以上人口患有心臟衰竭。因此，擴充性的心臟衰竭軟體對於減少不必要的住院治療、改進基於指南的藥物治療以及支持院外持續監測至關重要。

心臟衰竭軟體領域的變革性變化

心臟衰竭軟體領域連網型設備、雲端分析、與電子健康記錄的整合以及鼓勵早期療育的獎勵機制的融合而發生變革。醫院和循環系統科室正從間歇性的出院後追蹤轉向長期的數位化照護路徑，這些路徑整合了症狀、體重、血壓、心率、用藥依從性、實驗室檢查值以及設備產生的訊號。

人工智慧（AI）的累積影響

人工智慧 (AI) 正在加速心臟衰竭治療模式從被動應對轉向可預測的個人化照護。 AI 驅動的心臟衰竭軟體有助於識別疾病進展模式、優先處理高風險患者、輔助影像診斷，並精準定位基於指南的藥物治療中的不足。最有效的應用場景包括：將其整合到臨床醫生的工作流程中、在具有代表性的患者群體中檢驗，以及監測其表現變異性。

按地區分類的關鍵見解

北美地區憑藉其先進的循環系統醫療基礎設施、電子健康記錄（EHR）的高普及率、對遠端監測的保險報銷支持以及大量的已確診心臟衰竭患者，仍然是該技術應用的領先地區。在美國，以減少再入院率、管理慢性病和基於價值的合約為重點的醫療保健系統是需求的基礎；而在加拿大，重點則放在省級層面的整合式醫療模式、虛擬醫療服務以及面向農村和北部社區的遠距醫療服務上。

關鍵的群體特定見解

在東協地區，行動連線的普及、私立醫院網路的不斷擴展以及將循環系統醫療專業知識擴展到都市區的需求，正在塑造市場需求。在印尼、泰國、馬來西亞、越南、新加坡和菲律賓，支援多語言介面、行動優先工作流程、經濟實惠的遠端監測模式以及與基層醫療整合的供應商具有顯著優勢。

主要國家的概況

美國是創新和商業化的重要中心，這得益於先進的電子健康記錄（EHR）的普及、FDA對數位醫療的核准流程、聯邦醫療保險（Medicare）對遠距監測的報銷，以及保險公司對減少心臟衰竭住院的重視。在加拿大，省級綜合醫療、虛擬醫療項目和遠距醫療服務計劃正在湧現新的商機。在墨西哥和巴西，心血管代謝疾病負擔的加重、私人醫療網路的擴張以及數位醫療基礎設施的逐步現代化正在推動市場發展。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的心臟衰竭軟體，這些軟體需能對住院治療、藥物最佳化、醫療團隊效率和病患參與度產生可衡量的影響。隨著採購決策越來越注重實證醫學，供應商應投資於真實世界研究、同儕審查的結果以及符合支付方和醫療服務提供者優先事項的衛生經濟學模型。

調查方法

本執行摘要基於來自臨床、監管和公共衛生法律規範、醫療設備軟體的監管框架、報銷政策以及有關心臟衰竭和老齡化社會的流行病學資訊來源。

結論

隨著醫療保健系統面臨心臟衰竭衰竭盛行率上升、人口老化、人員短缺以及在降低成本的同時提高治療效果的壓力，心臟衰竭軟體在現代循環系統醫學中變得至關重要。最大的機會在於建立一個能夠連接臨床證據、可互通的工作流程、預測分析和以患者為中心的互動模式的平台。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：心臟衰竭軟體市場：依類型分類

  • 知識型
  • 非知識型

第8章：心臟衰竭軟體市場：依疾病類型分類

  • 先天性心臟衰竭
  • 左心臟衰竭
  • 右心臟衰竭

第9章：心臟衰竭軟體市場：依平台分類

  • 融合的
  • 獨立版

第10章：心臟衰竭軟體市場：依應用領域分類

  • 臨床決策支持
  • 資料分析
  • 與電子健康記錄整合
  • 行動端和以患者為中心的應用程式
  • 預測分析與風險分層工具
  • 遠端監控和遠端醫療平台

第11章：心臟衰竭軟體市場：依最終用戶分類

  • 診所
  • 居家照護環境
  • 醫院

第12章：心臟衰竭軟體市場：依部署模式分類

  • 基於雲端的系統
  • 現場
  • 基於網路的

第13章：心臟衰竭軟體市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：心臟衰竭軟體市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：心臟衰竭軟體市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • AliveCor, Inc.
  • Astellas Pharma Inc.
  • Axis Clinical Software, Inc.
  • Biofourmis Inc.
  • Biome.io
  • BIOPAC Systems Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cardiac RMS, LLC by DocGo, Inc.
  • CitiusTech Inc.
  • Cleerly, Inc.
  • CV Medical Software
  • Dyad Medical Inc.
  • Eko Health Inc.
  • Elucid Bioimaging Inc.
  • Endotronix, Inc
  • Epic Systems Corporation
  • Foundry Innovation & Research 1 Ltd.
  • GE HealthCare Technologies Inc.
  • Heart Input Output Inc.
  • Implicity
  • International Business Machines Corporation
  • iRhythm Technologies, Inc.
  • Koninklijke Philips NV
  • Medtronic PLC
  • N. Harris Computer Corporation
  • NorthEast Monitoring, Inc.
  • Oracle Corporation
  • PaceMate, LLC
  • Pacertool AS
  • Precordior Ltd.
  • Siemens AG
  • Ultromics Limited
  • VectraCor Inc.
  • VUNO Inc.
  • ZOLL Medical Corporation
Product Code: MRR-437E9896A560

The Heart Failure Software Market is projected to grow by USD 8.59 billion at a CAGR of 7.42% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.20 billion
Estimated Year [2026] USD 5.58 billion
Forecast Year [2032] USD 8.59 billion
CAGR (%) 7.42%

Heart failure software has moved from a supporting clinical tool to a core digital infrastructure layer for cardiology, population health, and value-based care. The category spans remote patient monitoring, clinical decision support, echocardiography and imaging analytics, care coordination, patient engagement, medication optimization, and interoperable data platforms used across hospitals, ambulatory practices, home health, and payers.

Demand is grounded in the clinical burden of heart failure: prevalence rises sharply with age, and leading cardiology societies estimate that heart failure affects about 1% to 2% of adults in developed markets and more than 10% of people over age 70. This makes scalable heart failure management software critical for reducing avoidable admissions, improving guideline-directed medical therapy, and supporting continuous monitoring beyond the hospital setting.

Transformative Shifts in the Heart Failure Software Landscape

The heart failure software landscape is being reshaped by the convergence of connected devices, cloud-based analytics, electronic health record integration, and reimbursement models that reward earlier intervention. Hospitals and cardiology groups are moving from episodic post-discharge follow-up to longitudinal digital pathways that combine symptoms, weight, blood pressure, heart rate, medication adherence, laboratory values, and device-generated signals.

A major shift is the operationalization of remote patient monitoring and virtual care. In the United States, Medicare reimbursement codes for remote physiologic monitoring and remote therapeutic monitoring have supported broader adoption, while Europe's digital health frameworks and national telehealth programs have encouraged structured deployment. At the same time, cybersecurity, clinical validation, interoperability, and clinician workflow fit have become decisive purchasing criteria.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating the shift from reactive heart failure management to predictive, personalized care. AI-enabled heart failure software can help identify deterioration patterns, prioritize high-risk patients, support imaging interpretation, and flag gaps in guideline-directed medical therapy. The strongest use cases are those embedded into clinician workflows, validated on representative populations, and monitored for performance drift.

The cumulative impact of AI is also changing competitive expectations. Buyers increasingly evaluate solutions on explainability, data governance, model validation, integration with EHR systems, and the ability to reduce alert fatigue. Regulatory oversight for software as a medical device, including FDA guidance and the European Union Medical Device Regulation, reinforces the need for transparent evidence, post-market monitoring, and responsible AI controls.

Key Regional Insights

North America remains a leading adoption region due to advanced cardiology infrastructure, EHR penetration, reimbursement support for remote monitoring, and a large diagnosed heart failure population. The United States anchors demand through health systems focused on readmission reduction, chronic care management, and value-based contracts, while Canada emphasizes integrated provincial care models, virtual health access, and remote care for rural and northern communities.

Europe benefits from mature public health systems, strong cardiology guidelines, and increasing digital health regulation under European frameworks. Germany, France, Italy, Spain, and the United Kingdom are prioritizing hospital-at-home models, telemonitoring pathways, virtual wards, and interoperable records. Asia-Pacific is expanding adoption as China, Japan, India, Australia, and South Korea address aging populations, cardiometabolic disease, and uneven specialist access through mobile health, connected devices, and AI-enabled clinical workflows.

Latin America, the Middle East, and Africa show rising need but more varied infrastructure maturity. Brazil and Mexico are advancing private-sector digital cardiology and public health modernization, while broader Latin American adoption depends on affordability, connectivity, and integration with fragmented care systems. GCC countries in the Middle East are investing in smart hospitals, national health information exchanges, and digital chronic disease programs. Across Africa, mobile-first care, workforce efficiency, earlier detection, and scalable follow-up tools are central to improving heart failure management where specialist access remains limited.

Key Group Insights

Within ASEAN, demand is shaped by high mobile connectivity, expanding private hospital networks, and the need to extend cardiology expertise beyond urban centers. Software vendors that support multilingual interfaces, mobile-first workflows, affordable remote monitoring models, and integration with primary care are better positioned across Indonesia, Thailand, Malaysia, Vietnam, Singapore, and the Philippines.

The GCC is advancing heart failure software through national digital health strategies, smart hospital investment, and growing attention to diabetes, obesity, hypertension, and cardiovascular risk. The European Union emphasizes privacy, interoperability, clinical evidence, and regulated digital health adoption, making compliance with GDPR, MDR, and emerging AI rules central to commercialization.

BRICS markets offer scale and diverse adoption pathways, from China's hospital digitization to India's mobile health ecosystem, Brazil's expanding private networks, Russia's cardiovascular disease management needs, and South Africa's demand for scalable specialist support. G7 countries represent high-value markets where evidence generation, reimbursement, cybersecurity, and integration with established EHR systems determine competitive success. NATO countries overlap substantially with advanced digital health markets, where resilience, data security, trusted infrastructure, and continuity of care are increasingly important procurement themes.

Key Country Insights

The United States is a major innovation and commercialization hub, supported by advanced EHR adoption, FDA pathways for digital health, Medicare remote monitoring reimbursement, and payer interest in reducing heart failure admissions. Canada offers opportunities through integrated provincial care, virtual care programs, and remote access initiatives. Mexico and Brazil are driven by growing cardiometabolic disease burdens, expanding private healthcare networks, and gradual modernization of digital health infrastructure.

In Europe, the United Kingdom emphasizes NHS digital transformation, virtual wards, and community-based heart failure management. Germany supports regulated digital health innovation and interoperability initiatives, France prioritizes telemonitoring reimbursement pathways, and Italy and Spain focus on regional care coordination and hospital-to-home models. Russia's market is shaped by domestic healthcare digitization and large cardiovascular disease needs.

China is scaling hospital digitization, connected care, and AI-enabled clinical platforms to support large patient volumes. India is advancing mobile-first chronic disease management through its digital public infrastructure and expanding telehealth use. Japan is focused on aging-related care efficiency and integrated monitoring for older adults, while Australia supports remote access for dispersed populations and chronic disease management across metropolitan and rural settings. South Korea combines advanced broadband infrastructure, strong digital hospital adoption, and policy support for connected healthcare innovation.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated heart failure software that demonstrates measurable impact on admissions, medication optimization, care team efficiency, and patient engagement. Procurement decisions are increasingly evidence-led, so vendors should invest in real-world studies, peer-reviewed outcomes, and health-economic models tailored to payer and provider priorities.

Software strategy should emphasize interoperability with EHRs, connected devices, pharmacy systems, imaging platforms, claims data, and patient portals. Vendors should design for clinician workflow, minimize alert fatigue, support equity across age and literacy groups, and implement rigorous cybersecurity and privacy controls. Partnerships with health systems, device manufacturers, payers, home health providers, and cardiology networks can accelerate adoption and strengthen data depth.

Research Methodology

This executive summary is built on secondary research from recognized clinical, regulatory, and public health sources, including cardiology society guidelines, government digital health programs, regulatory frameworks for software as a medical device, reimbursement policies, and epidemiological evidence on heart failure prevalence and aging populations.

The analysis synthesizes verified market signals across regions, groups, and countries by evaluating adoption drivers, clinical needs, infrastructure maturity, reimbursement environments, regulatory requirements, data protection rules, and technology readiness. Insights were screened for relevance to heart failure software, including remote monitoring, AI-enabled decision support, imaging analytics, care coordination, patient engagement, medication optimization, and interoperable clinical platforms.

Conclusion

Heart failure software is becoming essential to modern cardiovascular care as health systems face rising prevalence, aging populations, workforce constraints, and pressure to improve outcomes at lower cost. The strongest opportunities lie in platforms that connect clinical evidence, interoperable workflows, predictive analytics, and patient-centered engagement.

Artificial intelligence, remote monitoring, and value-based care will continue to define the direction of heart failure software, but trust will be the decisive differentiator. Vendors that prove clinical value, protect data, integrate seamlessly, and support equitable access are positioned to lead the next phase of digital heart failure management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Heart Failure Software Market, by Type

  • 7.1. Knowledge Based
  • 7.2. Non-Knowledge Based

8. Heart Failure Software Market, by Disease Type

  • 8.1. Congenital Heart Failure
  • 8.2. Left-Sided Heart Failure
  • 8.3. Right-Sided Heart Failure

9. Heart Failure Software Market, by Platform

  • 9.1. Integrated
  • 9.2. Standalone

10. Heart Failure Software Market, by Application

  • 10.1. Clinical Decision Support
  • 10.2. Data Analytics
  • 10.3. Electronic Medical Record Integration
  • 10.4. Mobile & Patient-centric Applications
  • 10.5. Predictive Analytics & Risk Stratification Tools
  • 10.6. Remote Monitoring & Telehealth Platform

11. Heart Failure Software Market, by End-User

  • 11.1. Clinics
  • 11.2. Homecare Settings
  • 11.3. Hospitals

12. Heart Failure Software Market, by Deployment Model

  • 12.1. Cloud-Based Systems
  • 12.2. On-Premises
  • 12.3. Web-Based

13. Heart Failure Software Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Heart Failure Software Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Heart Failure Software Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. AliveCor, Inc.
  • 17.3. Astellas Pharma Inc.
  • 17.4. Axis Clinical Software, Inc.
  • 17.5. Biofourmis Inc.
  • 17.6. Biome.io
  • 17.7. BIOPAC Systems Inc.
  • 17.8. Boston Scientific Corporation
  • 17.9. Canon Medical Systems Corporation
  • 17.10. Cardiac RMS, LLC by DocGo, Inc.
  • 17.11. CitiusTech Inc.
  • 17.12. Cleerly, Inc.
  • 17.13. CV Medical Software
  • 17.14. Dyad Medical Inc.
  • 17.15. Eko Health Inc.
  • 17.16. Elucid Bioimaging Inc.
  • 17.17. Endotronix, Inc
  • 17.18. Epic Systems Corporation
  • 17.19. Foundry Innovation & Research 1 Ltd.
  • 17.20. GE HealthCare Technologies Inc.
  • 17.21. Heart Input Output Inc.
  • 17.22. Implicity
  • 17.23. International Business Machines Corporation
  • 17.24. iRhythm Technologies, Inc.
  • 17.25. Koninklijke Philips N.V.
  • 17.26. Medtronic PLC
  • 17.27. N. Harris Computer Corporation
  • 17.28. NorthEast Monitoring, Inc.
  • 17.29. Oracle Corporation
  • 17.30. PaceMate, LLC
  • 17.31. Pacertool AS
  • 17.32. Precordior Ltd.
  • 17.33. Siemens AG
  • 17.34. Ultromics Limited
  • 17.35. VectraCor Inc.
  • 17.36. VUNO Inc.
  • 17.37. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART FAILURE SOFTWARE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HEART FAILURE SOFTWARE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HEART FAILURE SOFTWARE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HEART FAILURE SOFTWARE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART FAILURE SOFTWARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL HEART FAILURE SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL KNOWLEDGE BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL KNOWLEDGE BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL KNOWLEDGE BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NON-KNOWLEDGE BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-KNOWLEDGE BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON-KNOWLEDGE BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONGENITAL HEART FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONGENITAL HEART FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONGENITAL HEART FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LEFT-SIDED HEART FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LEFT-SIDED HEART FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LEFT-SIDED HEART FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RIGHT-SIDED HEART FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RIGHT-SIDED HEART FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RIGHT-SIDED HEART FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTEGRATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTEGRATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTEGRATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STANDALONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STANDALONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STANDALONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL DECISION SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL DECISION SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL DECISION SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DATA ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DATA ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DATA ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ELECTRONIC MEDICAL RECORD INTEGRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ELECTRONIC MEDICAL RECORD INTEGRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ELECTRONIC MEDICAL RECORD INTEGRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MOBILE & PATIENT-CENTRIC APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MOBILE & PATIENT-CENTRIC APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MOBILE & PATIENT-CENTRIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PREDICTIVE ANALYTICS & RISK STRATIFICATION TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PREDICTIVE ANALYTICS & RISK STRATIFICATION TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PREDICTIVE ANALYTICS & RISK STRATIFICATION TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL REMOTE MONITORING & TELEHEALTH PLATFORM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL REMOTE MONITORING & TELEHEALTH PLATFORM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL REMOTE MONITORING & TELEHEALTH PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CLOUD-BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CLOUD-BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CLOUD-BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ON-PREMISES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ON-PREMISES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ON-PREMISES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WEB-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL WEB-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL WEB-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 116. GCC HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 120. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 122. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 137. G7 HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 138. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 141. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 143. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 144. NATO HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 148. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 150. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 159. CANADA HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 163. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 165. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 166. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 170. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 172. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 173. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 177. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 179. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 187. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 191. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 193. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 194. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 198. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 200. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 201. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 205. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 207. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 208. ITALY HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 212. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 214. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 215. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 219. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 221. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 229. INDIA HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 233. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 235. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 236. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 240. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 242. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 243. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 247. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 249. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 250. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 254. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 256. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)